Yagmur AKDAG, Tugba GULSUN, Nihan IZAT, Levent ONER, Selma SAHİN, Meltem CETİN

Evaluation of preparation methods for orally disintegrating tablets

Oral disintegrating tablets (ODT) are orally administered solid dosage forms commonly used in pediatric and geriatric patients with difficulty in swallowing. The lack of need for water during the use of ODTs is another advantage that increases patient compliance. Many methods are used for the production of ODTs such as direct com-pression (DC), freeze-drying (FD), spray drying, 3-D printing, melt granulation, phase transition process, molding, sublimation, mass extrusion, cotton candy process. Since the ODTs produced are aimed to disintegrate and dissolve rapidly, and consequently act quickly, the production method parameters need to be optimized in line with the critical product parameters. In this study, the most widely used manufacturing methods (especially DC and FD) for ODT and in vitro quality control tests of ODT are evaluated.

PDF

___

1. Gulsun T, Ozturk N, Kaynak M, et al. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression. Pharmazie. 2017;72:389-94.

2. Olmez SS, Vural I. Advantages and quality control of orally disintegrating tablets. FABAD J Pharm Sci. 2009;34:167-72.

3. Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review. Trop J Pharm Res. 2009;8:161-172.

4. Nagar P, Singh K, Chauhan I, et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation. J Appl Pharm Sci. 2011;1(04):35-45.

5. Gulsun T, Akdag Cayli Y, Izat N, et al. Development and evaluation of terbutaline sulfate orally disintegrating tablets by direct compression and freeze drying methods. J Drug Deliv Sci Technol. 2018;46:251-8.

6. Badgujar B, Mundada A. The technologies used for developing orally disintegrating tablets: a review. Acta Pharm. 2011;61:117-39.

7. Ahmed IS, Nafadi MM, Fatahalla FA. Formulation of a fast-Dissolving ketoprofen tablet using freeze-drying in blisters technique. Drug Dev Ind Pharm. 2006;32:437-42.

8. Mishra DN, Bindal M, Singh SK, et al. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets. Pharm Bull. 2006;54:99-102.

9. Tanimura S, Tahara K, Takeuchi H. Spray-dried composite particles of erythritol and porous silica for orally disintegrating tablets prepared by direct tableting. Powder Technol. 2015;286:444-50.

10. Bandari S, Mittapalli RK, Gannu R. Orodispersible tablets: An overview. Asian J Pharm Sci. 2014;2:2-11.

11. Hannan P, Khan J, Khan A, et al. Oral dispersible system: A new approach in drug delivery system. Indian J Pharm Sci. 2016;78:2.

12. Dey P, Maiti S. Orodispersible tablets: A new trend in drug delivery. J Nat Sc Biol Med. 2010;1:2.

13. Kakar S, Singh R, Kumar S. Orodispersible tablets: an overview. MOJ Proteomics Bioinform. 2018;7:180-2.

14. Van Scoik KG. Solid pharmaceutical dosage in tablet triturate form and method of producing same. Google Patents; 1992.

15. Hirsh J, Midha K, Hirsh M, Lo W-Y. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration. Google Patents; 2005.

16. Koizumi K-i, Watanabe Y, Morita K, et al. New method of preparing high-porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm. 1997;152:127-31.

17. Kuno Y, Kojima M, Ando S, et al. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. J Controlled Release. 2005;105:16-22.

18. Kuno Y, Kojima M, Nakagami H, et al. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol. Eur J Pharm Biopharm. 2008;69(3):986-92.

19. Patil MG, Kakade SM, Pathade SG. Formulation and evaluation of orally disintegrating tablet containing tramadol hydrochloride by mass extrusion technique. J Appl Pharm Sci. 2011;1:178.

20. Shukla D, Chakraborty S, Singh S, et al. Mouth dissolving tablets I: An overview of formulation technology. Sci Pharm. 2009;77:309-26.

21. Myers GL, Battist GE, Fuisz RC. Process and apparatus for making rapidly dissolving dosage units and product therefrom. Google Patents; 1999.

22. Chivers TE. Process for making candy floss. Google Patents; 1971.

23. Lai F, Pini E, Angioni G, et al. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets. Eur J Pharm Biopharm. 2011;79:552-8.

24. Kumar RS, Yagnesh TNS. Oral dissolving films: an effective tool for fast therapeutic action. J Drug Deliv Ther. 2019;9:492-500.

25. Liew KB, Tan YTF, Peh KK. Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer Disease. AAPS PharmSciTech. 2012;13:134-42.

26. Lai F, Franceschini I, Corrias F, Sala MC, Cilurzo F, Sinico C, et al. Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study. Carbohydr Polym. 2015;121:217-23.

27. Puttewar T, Kshirsagar M, Chandewar A, et al. Formulation and evaluation of orodispersible tablet of taste masked doxylamine succinate using ion exchange resin. J King Saud Univ Sci. 2010;22:229-40.

28. Ph. Eur. 8th (European Pharmacopoeia, eighth ed.), 2014. http://online6.edqm.eu/ep802/ (accessed 10 August 2019), Council of Europe.

29. Kamboj M, Goyal S, Rakha P, et al. Formulation and evaluation of metformin oro-dispersible tablets. Acta Pol Pharm. 2011;68:717-23.

30. Malke S, Shidhaye S, Kadam V. Formulation and evaluation of oxcarbazepine fast dissolve tablets. Indian J Pharm Sci. 2007;69:211.

31. Elkhodairy KA, Hassan MA, Afifi SA. Formulation and optimization of orodispersible tablets of flutamide. Saudi Pharm J. 2014;22:53-61.

32. Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm. 2009;73:162-71.

33. Li M, Zhang T, Zhu L, et al. Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway. Int J Pharm. 2017;528:163-71.

34. AlHusban F, Perrie Y, Mohammed AR. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets. Eur J Pharm Biopharm. 2011;79:627-34.

35. Dobetti L. Fast-melting tablets: Developments and technologies. Pharm Technol Eur. 2000;12:32-42.